The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)

Journal of the Neurological Sciences

Volumn 288, Issue 1-2, 2010, Pages 1-12

  Strong, Michael J ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

FUS TLS; Neurodegeneration; RNA binding proteins; RNA metabolism; TDP 43

Indexed keywords

ANGIOGENIN; COPPER ZINC SUPEROXIDE DISMUTASE; PROTEIN FUS; RNA BINDING PROTEIN; RNA HELICASE; SENATAXIN; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; COMPLEX FORMATION; CYTOSOL; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; MOLECULAR INTERACTION; MOLECULAR WEIGHT; MOTONEURON; PRIORITY JOURNAL; REVIEW; RNA BINDING; RNA DEGRADATION; RNA METABOLISM; RNA SPLICING; RNA STABILITY; RNA TRANSLATION; RNA TRANSPORT;

AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL TRANSPORT, ACTIVE; HUMANS; PROTEIN BIOSYNTHESIS; RNA; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 71049166754     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.09.029     Document Type: Review

References (168)

1. Strong M.J. The evidence for ALS as a multisystems disorder of limited phenotypic expression. Can J Neurol Sci 28 (2001) 283-298
2. Strong M.J. The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 9 (2008) 323-338
3. Strong M.J., Grace G.M., Freedman M., Lomen-Hoerth C., Woolley S., Goldstein L.H., et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10 (2009) 131-146
4. Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillée S., Rule M., et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302 (2003) 113-117
5. Moisse K., and Strong M.J. Innate immunity in amyotrophic lateral sclerosis. Biochim Biophys Acta 1762 (2006) 1083-1093
6. Sargsyan S.A., Monk P.N., and Shaw P.J. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 51 (2005) 241-253
7. Nguyen M.D., D'Aigle T., Gowing G., Julien J.-P., and Rivest S. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J Neurosci 24 (2004) 1340-1349
8. Ferri A., Nencini M., Casciati A., Cozzolino M., Angelini D.F., Longone P., et al. Cell death in amyotrophic lateral sclerosis: interplay between neuronal and glial cells. FASEB J 18 (2004) 1261-1293
9. Strong M.J., Kesavapany S., and Pant H.C. The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?. J Neuropathol Exp Neurol 64 (2005) 649-664
10. Mather K., Watts F.Z., Carroll M., Whitehead P., Swash M., Cairn N., et al. Antibody to an abnormal protein in amyotrophic lateral sclerosis identifies Lewy body-like inclusion in ALS and Lewy bodies in Parkinson's disease. Neurosci Lett 160 (1993) 13-16
11. Migheli A., Pezzulo T., Attanasio A., and Schiffer D. Peripherin immunoreactive structures in amyotrophic lateral sclerosis. Lab Invest 68 (1993) 185-191
12. Malaspina A., Kaushik N., and de Belleroche J. A 14-3-3 mRNA is up-regulated in amyotrophic lateral sclerosis spinal cord. J Neurochem 75 (2000) 2511-2520
13. Kawamoto Y., Akiguchi I., Nakamura A., and Budka H. 14-3-3 proteins in Lewy body-like hyaline inclusion in patients with sporadic amyotrophic lateral sclerosis. Acta Neuropathol 108 (2004) 531-537
14. Chou S.M., Wang H.S., and Komai K. Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study. J Chem Neuroanat 10 (1996) 249-258
15. Ince P.G., Tomkins J., Slade J.Y., Thatcher N.M., and Shaw P.J. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS. J Neuropathol Exp Neurol 57 (1998) 895-904
16. Shibata N., Hirano A., and Klapporth K. Immunohistochemical demonstration of Cu/Zn superoxide dismutase in the spinal cord of patients with familial amyotrophic lateral sclerosis. Acta Histochem Cytochem 26 (1993) 619-621
17. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351 (2006) 602-611
18. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (2006) 130-133
19. Kwiatkowski Jr. T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323 (2009) 1205-1208
20. Vance C., Rogelj B., Hortobágyi T., De Vos K.J., Nishimura A.L., Sreedharan J., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323 (2009) 1208-1211
21. Bergeron C., Beric-Maskarel K., Muntasser S., Weyer L., Somerville M., and Percy M.E. Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J Neuropathol Exp Neurol 53 (1994) 221-230
22. Wong N., He B.P., and Strong M.J. Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J Neuropathol Exp Neurol 59 (2000) 972-982
23. Menzies F.M., Grierson A.J., Cookson M.R., Heath P.R., Tomkins J., Figlewicz D.A., et al. Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis. J Neurochem 82 (2002) 1118-1128
24. Bolognani F., and Perrone-Bizzozero N.I. RNA-protein interactions and control of mRNA stability in neurons. J Neurosci Res 86 (2008) 481-489
25. Lin A.C., and Holt C.E. Function and regulation of local axonal translation. Curr Opin Neurobiol 18 (2008) 60-68
26. Keene J., and Tenenbaum S.A. Eukaryotic mRNPs may represent posttranscriptional operons. Mol Cell 9 (2002) 1161-1167
27. Keene J.D. RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 8 (2007) 533-543
28. Anderson P., and Kedersha N. RNA granules. J Cell Biol 172 (2006) 803-808
29. Lukong K.E., Chang K., Khandjian E.W., and Richard S. RNA-binding proteins in human genetic disease. Trends Genet 24 (2008) 416-425
30. Wang I.-F., Wu L.-S., Chang H.-Y., and Shen C.-K.J. TDP-43, the signature protein of FTLD-U, is a neuronal activity responsive factor. J Neurochem 105 (2008) 797-806
31. Hirokawa N. mRNA transport in dendrites: RNA granules, motors and tracks. J Neurosci 26 (2006) 7139-7142
32. Kanai Y., Dohmae N., and Hirokawa N. Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron 43 (2004) 513-525
33. Kedersha N., Stoecklin G., Ayodele M., Yacono P., Lykke-Andersen J., Fritzler M.J., et al. Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J Cell Biol 169 (2005) 871-884
34. Anderson P., and Kedersha N. Stress granules: the Tao of RNA triage. Trends Biochem Sci 33 (2008) 141-150
35. Barbee S.A., Estes P.S., Cziko A.-M., Hillebrand J., Luedeman R.A., Coller J.M., et al. Staufen- and FMRP-containing neuronal RNPs are structurally and functionally related to somatic P bodies. Neuron 52 (2006) 997-1009
36. Lowery A.J., Miller N., McNeill R.E., and Kerin M.J. MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Clin Cancer Res 14 (2008) 360-365
37. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319 (2008) 1668-1672
38. Gao F.-B. Posttranscriptional control of neuronal development by microRNA networks. Trends Neurosci 31 (2008) 20-26
39. Schratt G.M., Tuebing F., Nigh E.A., Kane C.G., Sabatini M.E., Kiebler M., et al. A brain-specific microRNA regulates dendritic spine development. Nature 439 (2006) 283-289
40. Nelson P.T., and Keller J.N. RNA in brain disease: no longer just "the messenger in the middle". J Neuropathol Exp Neurol 66 (2007) 461-468
41. Nelson P.T., Wang W.-X., and Rajeev B.W. MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol 18 (2008) 130-138
42. Hébert S.S., and De Strooper B. Alteration of the microRNA network cause neurodegenerative disease. Trends Neurosci 32 (2009) 199-206
43. Boissonneault V., Plante I., Rivest S., and Provost P. MicroRNA-298 and microRNA-328 regulate expression of mouse β-amyloid precursor protein converting enzyme 1. J Biol Chem 284 (2009) 1971-1981
44. Saba R., Goodman C.D., Huzarewich R.L.C.H., Robertson C., and Booth S.A. miRNA signature of prion induced neurodegeneration. PLoS ONE 3 (2008) e3652
45. Sun B.K., and Tsao H. Small RNAs in development and disease. J Am Acad Dermatol 59 (2008) 725-737
46. Pillai R.S. MicroRNA function: multiple mechanisms for a tiny RNA?. RNA 11 (2005) 1753-1761
47. Gregory R.I., Yan K., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., et al. The microprocessor complex mediates the genesis of microRNAs. Nature 432 (2004) 235-240
48. Liu X., Fortin K., and Mourleatos Z. MicroRNAs: biogenesis and molecular functions. Brain Pathol 18 (2008) 121
49. Rossi J.J. RNAi and the P-body connection. Nat Cell Biol 7 (2005) 643-644
50. Jabri E. P-bodies take a RISC. Nat Struct Mol Biol 12 (2005) 564
51. Liu J., Valencia-Sanchez M.A., Hannon G.J., and Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 7 (2005) 719-726
52. Li Q., Lee J.-A., and Black D.L. Neuronal regulation of alternative pre-mRNA splicing. Nat Rev Neurosci 8 (2007) 819-831
53. Corbo M., and Hays A.P. Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease. J Neuropathol Exp Neurol 51 (1999) 531-537
54. Robertson J., Doroudchi M.M., Nguyen M.D., Durham H.D., Strong M.J., Shaw G., et al. A neurotoxic peripherin splice variant in a mouse model of ALS. J Cell Biol 160 (2003) 939-949
55. Xiao S., Tjostheim S., Sanelli T., McLean J.R., Horne P., Fan Y., et al. An aggregate-inducing peripherin isoform generated through intron retention is upregulated in amyotrophic lateral sclerosis and associated with disease pathology. J Neurosci 28 (2008) 1833-1840
56. Sanelli T., Xiao S., Horne P., Bilbao J., Zinman L., and Robertson J. Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 66 (2007) 1147-1153
57. Lin C.-L.G., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., et al. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20 (1998) 589-602
58. Meyer T., Fromm A., Münch C., Schwalenstöcker B., Fray A.E., Ince P.G., et al. The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals. J Neurol Sci 170 (1999) 45-50
59. Honig L.S., Chambliss D.D., Bigio E.H., Carroll S.L., and Elliott J.L. Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls. Neurology 55 (2000) 1082-1088
60. Flowers J.M., Powell J.F., Leigh P.N., Andersen P., and Shaw C.E. Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis. Ann Neurol 49 (2001) 643-649
61. Lunn M.R., and Wang C.H. Spinal muscular atrophy. Lancet 371 (2008) 2120-2133
62. Zhang H.L., Pan F., Hong D., Shenoy S.M., Singer R.H., and Bassell G.J. Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization. J Neurosci 23 (2003) 6627-6637
63. Zhang H., Xing L., Rossoll W., Wichterle H., Singer R.H., and Bassell G.J. Multiprotein complexes of the survival of motor neuron protein SMN with gemins traffic to neuronal processes and growth cones of motor neurons. J Neurosci 26 (2006) 8622-8632
64. Rossoll W., Kröning A.-K., Ohndorf U.-M., Steegborn C., Jablonka S., and Sendtner M. Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons?. Hum Mol Genet 11 (2002) 93-105
65. McWhorter M.L., Monani U.R., Burghes A.H.M., and Beattie C.E. Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J Cell Biol 162 (2009) 919-931
66. Wu D., Wenhao Y., Kishikawa H., Folkerth R.D., Iafrate A.J., Shen Y., et al. Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol 62 (2007) 609-617
67. Hatzi E., and Badet J. Expression of receptors for human angiogenin in vascular smooth muscle cells. Eur J Biochem 260 (1999) 825-832
68. Yamasaki S., Ivanov P., Hu G., and Anderson P. Angiogenin cleaves tRNA and promotes stress-induced translational repression. J Cell Biol 185 (2009) 35-42
69. Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet 34 (2006) 411-413
70. Gellera C., Colobrita C., Ticozzi N., Castellotti B., Bragato C., Ratti A., et al. Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis. Neurogenetics 9 (2008) 33-40
71. Crabtree B., Thiyagarajan N., Prior S.H., Wilson P., Iyer S., Ferns T., et al. Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis. Biochem 46 (2007) 11810-11818
72. Corrado L., Battistini S., Penco S., Bergamaschi L., Testa L., Ricci C., et al. Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population. J Neurol Sci 258 (2007) 123-127
73. van Es M.A., Diekstra F.P., Baas F., Bourque P.R., Schelhaas H.J., Strengman E., et al. A case of ALS-FTD in a large FALS pedigree with a K17I ANG mutation. Neurology 72 (2009) 287-288
74. Gao X., and Xu Z. Mechanisms of action of angiogenin. Acta Biochim Biophys Sin 40 (2008) 619-624
75. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28 (2001) 131-138
76. Zheng C., Nennesmo I., Fadeel B., and Henter J.-I. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann Neurol 56 (2004) 564-567
77. Wang Y., Mao X.O., Xie L., Banwait S., Marti H.H., Greenberg D.A., et al. Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J Neurosci 27 (2007) 304-307
78. Kieran D., Sebastia J., Greenway M.J., King M.A., Connaughton D., Concannon C.G., et al. Control of motor neuron survival by angiogenin. J Neurosci 28 (2008) 14056-14061
79. Lambrechts D., Storkebaum E., Morimoto M., Del-Favero J., Desmet F., Marklund S.L., et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34 (2003) 383-394
80. Chen Y.-Z., Bennett C.L., Huynh H.M., Blair I.P., Puls I., Irobi J., et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 74 (2004) 1128-1135
81. Chen Y.-Z., Hashemi S.H., Anderson S.K., Huang Y., Moreira M.-C., Lynch D.R., et al. Senataxin, the yeast Sen1p othologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neruon disease. Neurobiol Dis 23 (2006) 97-108
82. Zhao Z.-H., Chen W.-Z., Wu Z.-Y., Wang N., Zhao G.-X., Chen W.-J., et al. A novel mutation in senataxin gene identified in a Chinese patient with sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10 (2009) 118-122
83. Grohmann K., Shuelke M., Diers A., Hoffmann K., Lucke B., Adams C., et al. Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet 29 (2001) 75-77
84. Tanner N.K., and Linder P. DExD/H Box RNA helicases: from generic motors to specific dissociation functions. Mol Cell 8 (2001) 251-262
85. Hargrove J.L., and Schmidt F.H. The role of mRNA and protein stability in gene expression. FASEB J 3 (1989) 2360-2370
86. Arao Y., Kikuchi A., Kishida M., Yonekura M., Inoue A., Yasuda S., et al. Stability of A + U-rish element binding factor 1 (AUF-1)-binding messenger ribonucleic acid correlates with the subcellular relocalization of AUF1 in the rat uterus upon estrogen treatment. Mol Endocrinol 18 (2004) 2255-2267
87. Wilson G.M., Lu J., Sutphen K., Suarez Y., Sinha S., Brewer B., et al. Phosphorylation of p40AUF1 regulates binding to A-U-rich mRNA-destabilizing elements and protein-induced changes in ribonucloprotein structure. J Biol Chem 278 (2003) 33039-33048
88. Gringhuis S.I., García-Vallejo J.J., van het Hof B., and van Dijk W. Convergent actions of IκB kinase β and protein kinase Cδ modulate mRNA stability through phosphorylation of 14-3-3β complexed with tristetraprolin. Mol Cell Biol 25 (2005) 6454-6463
89. Sun L., Stoecklin G., van Way S., Hinkovska-Galcheva V., Guo R.-F., Anderson P., et al. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-α mRNA. J Biol Chem 282 (2007) 3766-3777
90. Szaro BG, Strong MJ. Post-transcriptional control of neurofilaments: new roles in development, regeneration and neurodegenerative disease. Trends Neurosci in press.
91. Ge W., Leystra-Lantz C., Wen W., and Strong M.J. Selective loss of trans-acting instability determinants of neurofilament mRNA in amyotrophic lateral sclerosis spinal cord. J Biol Chem 278 (2003) 26558-26563
92. Strong M.J., Volkening K., Hammond R., Yang W., Strong W.L., Leystra-Lantz C., et al. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci 35 (2007) 320-327
93. Ge W.W., Volkening K., Leystra-Lantz C., Jaffe H., and Strong M.J. 14-3-3 protein binds to the low molecular weight neurofilament (NFL) mRNA 3′ UTR. Mol Cell Neurosci 34 (2007) 80-87
94. Ge W.W., Wen W., Strong W.L., Leystra-Lantz C., and Strong M.J. Mutant copper/zinc superoxide dismutase binds to and destabilizes human low molecular weight neurofilament mRNA. J Biol Chem 280 (2005) 118-124
95. Cañete-Soler R., Wu J., Zhai J., Shamim M., and Schlaepfer W.W. p190RhoGEF binds to a destabilizing element in the 3′ untranslated region of light neurofilament subunit mRNA and alters the stability of the transcript. J Biol Chem 276 (2001) 32046
96. Cañete-Soler R., Silberg D.G., Gershon M.D., and Schlaepfer W.W. Mutation in neurofilament transgene implicates RNA processing in the pathogenesis of neurodegenerative disease. J Neurosci 19 (1999) 1272-1283
97. Nie Z., Wu J., Zhai J., Lin H., Ge W., Schlaepfer W.W., et al. Untranslated element in neurofilament mRNA has neuropathic effect on motor neurons of transgenic mice. J Neurosci 22 (2002) 7662-7670
98. Lin H., Zhai J., Cañete-Soler R., and Schlaepfer W.W. 3′ Untranslated region in a light neurofilament (NF-L) mRNA triggers aggregation of NF-L and mutant superoxide dismutase 1 proteins in neuronal cells. J Neurosci 24 (2004) 2716-2726
99. Lin H., Zhai J., and Schlaepfer W.W. RNA-binding protein is involved in aggregation of light neurofilament protein and is implicated in the pathogenesis of motor neuron degeneration. Hum Mol Genet 14 (2005) 3643-3659
100. Zhang H., Tan C.-F., Mori F., Tanji K., Kakita A., Takahashi H., et al. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol 115 (2008) 115-122
101. Higashi S., Eizo I., Yamamoto R., Minegishi M., Hino H., Fujisawa K., et al. Appearance of TDP-43 in Japanese frontotemporal lobar degeneration with ubiquitin-positive inclusions. Neurosci Lett 419 (2007) 213-218
102. Mackenzie I.R.A., Bigio E.H., Ince P.G., Geser F., Neumann M., Cairns N.J., et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61 (2007) 427-434
103. Geser F., Winton M.J., Kwong L.K., Xu Y., Xie S.X., Igaz L.M., et al. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol 115 (2008) 133-145
104. Mishra M., Paunesku T., Woloschak G.E., Siddique T., Zhu L., Lin S., et al. Gene expression analysis of frontotemporal lobar degeneration of the motor neuron disease type with ubiquitinated inclusions. Acta Neuropathol 114 (2007) 81-94
105. Snowden J., Neary D., and Mann D. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol 114 (2007) 31-38
106. Davidson Y., Kelley T., Mackenzie I.R.A., Pickering-Brown S., Du Plessis D., Neary D., et al. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 113 (2007) 521-533
107. Probst A., Taylor K.I., and Tolnay M. Hippocampal sclerosis dementia: a reappraisal. Acta Neuropathol 114 (2007) 335-345
108. Neumann M., Mackenzie I.R., Cairns N.J., Boyer P.J., Markesbery W.R., Smith C.D., et al. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neuropathol Exp Neurol 66 (2007) 152-157
109. Cairns N.J., Neumann M., Bigio E.H., Holm I.E., Troost D., Hatanpaa K.J., et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 171 (2007) 227-240
110. Nakashima-Yasuda H., Kunihiro U., Robinson J., Xie S.X., Hurtig H., Duda J.E., et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 114 (2007) 221-229
111. Lee E.B., Lee V.M.Y., Trojanowski Q., and Neumann M. TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system. Acta Neuropathol 115 (2008) 305-311
112. Yokoseki A., Shiga A., Tan C.-F., Tagawa A., Kaneko H., Koyama A., et al. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol 63 (2008) 538-542
113. Gitcho M.A., Baloh R.H., Chakraverty S., Mayo K., Norton J.B., Levitch D., et al. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 63 (2008) 535-538
114. Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40 (2008) 572-574
115. Winton M.J., Van Deerlin V.M., Kwong L.K., Yuan W., Wood E.M., Yu C.E., et al. A90V TDP-43 variant results in the aberrant localization of TDP-43 in vitro. FEBS Lett 582 (2008) 2252-2256
116. Kühnlein P., Sperfeld A.-D., Vanmassenhove B., Van Deerlin V., Lee V.M.Y., Trojanowski J.Q., et al. Two German kindreds with familial amytrophic lateral sclerosis due to TARDBP mutations. Arch Neurol 65 (2008) 1185-1189
117. Benajiba L., Le Ber I., Camuzat A., Lacoste M., Thomas-Anterion C., Couratier P., et al. Tardpb mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol 65 (2008) 470-473
118. Van Deerlin V.M., Leverenz J.B., Bekris L.M., Bird T.D., Yuan W., Elman L.B., et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histological analysis. Lancet Neurol 7 (2008) 416
119. Rutherford N.J., Zhang Y.J., Baker M., Gass J.M., Finch N.A., Xu Y.F., et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genetics 4 (2008) e1000193
120. Corrado L., Ratti A., Gellera C., Buratti E., Castellotti B., Carlomagno Y., et al. High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis. Hum Mutat 30 (2009) 688-694
121. Del Bo R., Ghezzi S., Corti S., Pandolfo M., Ranieri M., Santoro D., et al. TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations. Eur J Neurol 16 (2009) 727-732
122. Ou S.-H.I., Wu F., Harrich D., García-Martínez L.F., and Gaynor R.B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 69 (1995) 3584-3596
123. Buratti E., Dörk T., Zuccato E., Pagani F., Romano M., and Baralle F.E. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO 20 (2001) 1774-1784
124. Buratti E., and Baralle F.E. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem 276 (2001) 36337-36343
125. Wang H.-Y., Wang I.-F., Bose J., and Shen C.K.J. Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 83 (2004) 130-139
126. Wang I.-F., Reddy N.M., and Shen C.K.F. Higher order arrangement of the eukaryotic nuclear bodies. Proc Natl Acad Sci USA 99 (2002) 13583-13588
127. Buratti E., and Baralle F.E. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci 13 (2008) 867-878
128. Abhyankar M.M., Urekar C., and Reddi P.P. A novel CpG-free vertebrate insulator silences the testis-specific SP-10 gene in somatic tissues. J Biol Chem 282 (2007) 36143-36154
129. Ayala Y.M., Pagani F., and Baralle F.E. TDP-43 depletion rescues aberrant CFTR exon 9 skipping. FEBS Lett 580 (2006) 1339-1344
130. Buratti E., Brindisi A., Pagani F., and Baralle F.E. Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. Am J Hum Genet 74 (2004) 1322-1325
131. Moisse K., Volkening K., Leystra-Lantz C., Welch I., Hill T., and Strong M.J. Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy. Brain Res 1249 (2009) 202-211
132. Parker R., and Sheth U. P bodies and the control of mRNA translation and degradation. Mol Cell 25 (2007) 635-646
133. Makeyev A.V., and Liebhaber S.A. The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms. RNA 8 (2002) 265-278
134. Wilhelm J.E., and Vale R.D. RNA on the move: the mRNA localization pathway. J Cell Biol 123 (1993) 269-274
135. Krichevsky A.M., and Kosik K.S. Neuronal RNA granules: a link between RNA localization and stimulation-dependent translation. Neuron 32 (2001) 683-696
136. Chabanon H., Mickleburgh I., and Hesketh J. Zipcodes and postage stamps: mRNA localisation signals and their trans-acting binding proteins. Brief Funct Genomic Proteomic 3 (2004) 240-256
137. Shyu A.B., and Wilkinson M.F. The double lives of shuttling mRNA binding proteins. Cell 102 (2000) 135-138
138. Volkening K., Leystra-Lantz C., and Strong M.J. Human low molecular weight neurofilament (NFL) mRNA interacts with a predicted p190RhoGEF homologue (RGNEF). Amyotroph Lateral Scler (Jun 1 2009) 1-7 [Electronic publication ahead of print]
139. Iko Y., Kodama T.S., Kasai N., Oyama T., Morita E.H., Muto T., et al. Domain architectures and characterization of an RNA-binding protein, TLS. J Biol Chem 279 (2004) 44834-44840
140. Bisbal M., Wojnacki J., Peretti D., Ropolo A., Sesma J., Jausoro I., et al. KIF4 mediates anterograde translocation and positioning of ribosomal constituents to axons. J Biol Chem 284 (2009) 9489-9497
141. Levy J.R., and Holzbaur E.L.F. Cytoplasmic dynein/dynactin function and dysfunction in motor neurons. Int J Devl Neuroscience 24 (2006) 103-111
142. Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S., et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300 (2003) 808-812
143. Münch C., Rosenbohm A., Sperfeld A.-D., Uttner I., Reske S., Krause B.J., et al. Hetereozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann Neurol 58 (2005) 777-780
144. Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L., Tokito M., Mann E., et al. Mutant dynactin in motor neuron disease. Nat Genet 33 (2003) 455-456
145. Landers J.E., Melki J., Meininger V., Glass J.D., Van den Berg L.H., van Es M.A., et al. Reduced expression of kinesin-associated protein3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 106 (2009) 9004-9009
146. Shan X., Tashiro H., and Lin C.-L.G. The identification and characterization of oxidized RNAs in Alzheimer's disease. J Neurosci 23 (2003) 4913-4921
147. Tanaka M., Chock P.B., and Stadtman E.R. Oxidized messenger RNA induces translation errors. Proc Natl Acad Sci USA 104 (2007) 66-71
148. Nunomura A., Moreira P.I., Takeda A., Smith A., and Perry G. Oxidative damage and neurodegeneration. Curr Med Chem 14 (2007) 2968-2975
149. Chang Y., Kong Q., Shan X., Tian G., Ilieva H., Cleveland D.W., et al. Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS. PLoS ONE 3 (2008) e2849
150. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
151. Hadano S., Hand C.K., Osuga H., Yanagisawa Y., Otomo A., Devon R.S., et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 29 (2001) 166-173
152. Yang Y., Hentati A., Deng H.-X., Dabbagh O., Sasaki T., Hirano M., et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 29 (2001) 160-165
153. Hentati A., Bejaoui K., Pericak-Vance M.A., Hentati F., Speer M.C., Hung W.-Y., et al. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. Nat Genet 7 (1994) 425-428
154. Ben Hamida M., Hentati F., and Ben Hamida C. Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Brain 113 (1990) 347-363
155. Hand C.K., Khoris J., Salachas F., Gros-Louis F., Simoes Lopes A.A., Mayeux-Portas V., et al. A novel locus for familial amyotrophic lateral sclerosis on chromosome 18q. Am J Hum Genet 70 (2002) 251-256
156. Hentati A., Ouahchi K., Pericak-Vance M.A., Nijhawan D., Ahmad A., Yang Y., et al. Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers. Neurogenetics 2 (1998) 55-60
157. Abalkhail H., Mitchell J., Habgood J., Orrell R., and de Belleroche J. A new familial amyotrophic lateral sclerosis locus on chromosome 16q12.1-16q12.2. Am J Hum Genet 73 (2003) 383-389
158. Ruddy D.M., Parton M.J., Al-Chalabi A., Lewis C.M., Vance D., Smith B.N., et al. Two families with familal amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q. Am J Hum Genet 73 (2003) 396
159. Sapp P.C., Hosler B.A., McKenna-Yasek D., Chin W., Gann A., Genise H., et al. Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Am J Hum Genet 73 (2003) 397-403
160. Nishimura A.L., Mitne-Neto M., Silva H.C.A., Richieri-Costa A., Middleton S., Cascio D., et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 75 (2004) 822-831
161. Nishimura A.L., Mitne-Neto M., Silva H.C.A., Oliveira J.R.M., Vainzof M., and Zatz M. A novel locus for late onset amyotrophic lateral sclerosis/motor neurone disease variant at 20q13. J Med Genet 41 (2004) 315-320
162. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., et al. Association of missense and 5″-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393 (1998) 702-705
163. Lynch T., Sano M., Marder K.S., Bell K.L., Foster N.L., Defendini R.F., et al. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology 44 (1994) 1878-1884
164. Wilhelmsen K.C., Forman M.S., Rosen H.J., Alving L.I., Goldman J., Feiger J., et al. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and α-synuclein inclusions. Arch Neurol 61 (2004) 398-406
165. Zarranz J.J., Ferrer I., Lezcano E., Forcadas M.I., Eizaguirre B., Atarés B., et al. A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology 64 (2005) 1578-1585
166. Li X., Lu L., Bush D.J., Zhang X., Zheng L., Suswam E.A., et al. Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to the adenine/uridine-rich stability elements in the vascular endothelial growth factor 3′-untranslated region. J Neurochem 108 (2009) 1032-1044
167. Lu L., Zheng I., Viera L., Suswam E., Li Y., Li X., et al. Mutant Cu/Zn superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression. J Neurosci 27 (2007) 7929-7938
168. Rademakers R., Eriksen J.L., Baker M., Robinson T., Ahmed Z., Lincoln S.J., et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 17 (2008) 3631-3642